Etoricoxib-Cannabidiol Combo: Potential Role in Glioblastoma Treatment and Development of PLGA-Based Nanoparticles

Background: Glioblastoma (GBM) is the most frequently occurring primary malignant central nervous system tumor, with a poor prognosis and median survival below two years. Administration of a combination of non-steroidal anti-inflammatory drugs and natural compounds that exhibit a curative or prophyl...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuźmińska, Joanna, Sobczak, Agnieszka, Majchrzak-Celińska, Aleksandra, Żółnowska, Izabela, Gostyńska, Aleksandra, Jadach, Barbara, Krajka-Kuźniak, Violetta, Jelińska, Anna, Stawny, Maciej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459258/
https://www.ncbi.nlm.nih.gov/pubmed/37631318
http://dx.doi.org/10.3390/pharmaceutics15082104

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459258/
https://www.ncbi.nlm.nih.gov/pubmed/37631318
http://dx.doi.org/10.3390/pharmaceutics15082104

Ejemplares similares